Dear Mr./Ms.,
Sanyou Biopharmaceuticals is focusing on the integrated solution of therapeutic antibody discovery and development, and could offer kinds of services for therapeutic antibody R&D.
In terms of in vitro efficacy evaluation, our team is productive and reliable, and could finish the method development and model construction within weeks. Since the company's founding, they have fulfilled a variety of efficacy evaluations for many projects.
ADVANTAGES:
1) Fully Covered Bioassays
Tens of general assays are available, including ADCC, ADCP, CDC, MLR, Internalization, inhibition of cell proliferation, pro-inflammatory factor release, and other in vitro assays.
2) Various Target Cells
Dozens of popular target cell lines have been constructed and verified, including tumor specific antigens and immune checkpoints.
3) Target Cells of Different Mechanism
All sorts of luciferase reporter-based effector cell lines are also available, in addition to the high-quality primary cells isolated from PBMC.
4) All-around Customized Service
Bioassay method development, distinct target cell line construction and luciferase reporter-based cell line customization are available.
Make your efficacy evaluation easier!
AVAILABLE SERVICE:
ADCC, ADCP, apoptosis, CDC, cell proliferation/suppression, chemotaxis, co-stimulation, FACS binding/blocking/competition, MLR, internalization, inflammatory assay, primary cell isolation/induction and more.
SERVICE:
Note: If target cells are not cultured, it would take another week for preparation.
Do you need assistance with efficacy evaluation?
ABOUT US:
Sanyou Biopharmaceuticals is a leading international High-tech biotechnology company focused on research, development and providing integrated solutions for innovative antibody drug developments.
Sanyou is committed to building world-leading antibody drug discovery and development platforms of high-quality, high-throughput, integrated R&D and value transformation. Sanyou is dedicated in constructing a business ecosystem for therapeutic, R&D and diagnostic products and services, and collaborating with global biopharmaceutical, diagnostic, R&D companies to open a new era for the diagnosis and treatment of human diseases.
Since the founding in the year of 2015, Sanyou has been growing rapidly. As of November 2020, Sanyou has a professional team of more than 150 employees, of which more than 70% hold a PhD or master degree, and this team is deeply experienced in R&D and industrialization of innovative drugs. Sanyou has established an integrated R&D laboratory of several thousands of square meters with advanced facilities in Caohejing Hi-Tech Park in Shanghai. The laboratory have 10 functional modules and more than 40 core technology platforms, led by a series of super-trillion phage display antibody libraries, and followed by a full range of essential R&D platforms for innovative antibody drug discovery, antibody engineering, in vitro and in vivo efficacy screening, pharmaceutical properties analysis, cell line construction, and process development. Sanyou continues to provide new technologies, new products, services and solutions of "best quality, fastest speed and lowest cost". Sanyou has established friendly business relationships with more than 100 pharmaceutical companies, drug development organizations and diagnostic product development companies around the world.
“Excellence and innovation, pursuit of dreams, striving and evolving, for the benefit of patients”, holding these principles and beliefs, Sanyou looks forward to working with our customers and partners to build a long-term synergistic growth ecosystem and a healthy society.
You're welcome to send an email and tell us what's your need, and we will get back to you ASAP.
Sincerely.
Qingyang
Customer Specialist
Sanyou Biopharmaceuticals Co., Ltd.
Address: Building 6, No.188 Xinjunhuan Road,
Minhang District, Shanghai, China 201114
Email: service@sanyoubio.com
Tel: +86-21-3368 1627
Website: www.sanyoubio.com
|